Author:
Kanis J. A.,Oden A.,Johnell O.,Johansson H.,De Laet C.,Brown J.,Burckhardt P.,Cooper C.,Christiansen C.,Cummings S.,Eisman J. A.,Fujiwara S.,Glüer C.,Goltzman D.,Hans D.,Krieg M.-A.,La Croix A.,McCloskey E.,Mellstrom D.,Melton L. J.,Pols H.,Reeve J.,Sanders K.,Schott A-M.,Silman A.,Torgerson D.,van Staa T.,Watts N. B.,Yoshimura N.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference79 articles.
1. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141
2. Committee for Proprietary Medicinal Products (CPMP) (2001) Note for guidance on postmenopausal osteoporosis in women. European Agency for the Evaluation of Medicinal Products, London (CPMP/EWP/552/95 rev 1)
3. Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Rockville, MD
4. Royal College of Physicians (1999) Clinical Guidelines for strategies to prevent and treat osteoporosis. Royal College of Physicians, London
5. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D, on behalf of the European Foundation for Osteoporosis and Bone Disease (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 7:390–406
Cited by
991 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献